SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 6,076.25 |
Enterprise Value ($M) | 6,634.67 |
Book Value ($M) | 313.15 |
Book Value / Share | 4.93 |
Price / Book | 19.40 |
NCAV ($M) | -31.65 |
NCAV / Share | -0.50 |
Price / NCAV | -191.96 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.12 |
Return on Assets (ROA) | -0.12 |
Return on Equity (ROE) | -0.63 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.27 |
Current Ratio | 3.32 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 854.85 |
Assets | 1,199.65 |
Liabilities | 886.50 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Price T Rowe Associates Inc /md/ | 8.50 | -13.82 | |
13G/A | Fmr Llc | 7.15 | -6.95 | |
13G/A | Wellington Management Group Llp | 7.03 | -14.53 | |
13G/A | BlackRock, Inc. | 10.80 | 4.94 | |
13G/A | Vanguard Group Inc | 10.06 | 5.90 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
UNITED STATES | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
329,935 | 847,841 | 38.91 | |
88,282 | 358,292 | 24.64 | |
46,364 | 285,272 | 16.25 | |
70,138 | 334,913 | 20.94 | |
(click for more detail) |
Similar Companies | |
---|---|
BMEA – Biomea Fusion, Inc. | BMRN – BioMarin Pharmaceutical Inc. |
BOLT – Bolt Biotherapeutics, Inc. | CABA – Cabaletta Bio, Inc. |
CCCC – C4 Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io